keiWhat Is Nattokinase?
Nattokinase is a serine protease enzyme extracted from natto — a traditional Japanese food made from fermented soybeans. Discovered in 1987 by Dr. Hiroyuki Sumi at the University of Chicago, nattokinase was found to have remarkable fibrinolytic activity: the ability to dissolve fibrin, the protein mesh that forms blood clots.
Unlike pharmaceutical thrombolytics (clot-busting drugs) that are administered intravenously in emergency settings, nattokinase is orally bioavailable, well-tolerated, and has been studied extensively as a daily cardiovascular support supplement. It is one of the most researched natural compounds for circulatory health.
How Nattokinase Works: Fibrinolysis Explained
Blood clotting is a necessary survival mechanism — but when clots form inappropriately or fail to dissolve properly, they become a leading driver of heart attacks, strokes, deep vein thrombosis (DVT), and pulmonary embolism.
Nattokinase supports healthy clot resolution through multiple mechanisms:
- Direct fibrin degradation — nattokinase directly cleaves fibrin strands, breaking down existing clots
- Plasminogen activation — it enhances the body's own clot-dissolving system by activating plasminogen into plasmin
- tPA upregulation — it increases tissue plasminogen activator (tPA), the body's primary endogenous fibrinolytic agent
- PAI-1 inhibition — it inhibits plasminogen activator inhibitor-1 (PAI-1), which normally suppresses fibrinolysis
This multi-pathway approach makes nattokinase uniquely effective at maintaining healthy blood viscosity and circulatory flow.
Key Research & Clinical Evidence
Blood Pressure: A randomized controlled trial published in Hypertension Research (2008) found that nattokinase supplementation (2,000 FU/day for 8 weeks) significantly reduced both systolic and diastolic blood pressure compared to placebo.
Atherosclerosis: A 2017 study in Scientific Reports found nattokinase reduced carotid artery plaque size by 36.6% over 26 weeks, compared to statin therapy which reduced plaque by only 11.5% — a striking finding that generated significant research interest.
DVT Prevention: A study of long-haul airline passengers found nattokinase supplementation significantly reduced the incidence of deep vein thrombosis compared to placebo.
Cognitive Health: Emerging research suggests nattokinase may support cognitive function by improving cerebral blood flow and reducing fibrin accumulation in the brain — a factor implicated in vascular dementia and Alzheimer's disease.
Post-COVID & Spike Protein: Nattokinase has attracted significant attention in post-COVID research for its potential to degrade spike protein and address microclotting associated with long COVID. While research is ongoing, it has become one of the most discussed supplements in this context.
Dosing & Supplementation
Nattokinase is measured in Fibrinolytic Units (FU) rather than milligrams, as potency varies by preparation. Standard research doses range from 2,000 to 4,000 FU per day, typically divided into 1–2 doses.
Timing: Best taken on an empty stomach — either 30 minutes before meals or 2 hours after — to maximize absorption and fibrinolytic activity. Many practitioners recommend taking it before bed to support overnight circulatory maintenance.
Synergistic stacking:
- Serrapeptase — another fibrinolytic enzyme with complementary mechanisms; often combined for enhanced effect
- Omega-3 fatty acids — support healthy blood viscosity and anti-inflammatory pathways
- Vitamin K2 MK-7 — directs calcium away from arteries; pairs well for cardiovascular protection
- Magnesium — supports vascular tone and blood pressure regulation
Safety & Contraindications
Nattokinase has a strong safety profile in healthy individuals at standard doses. However, due to its blood-thinning properties, important precautions apply:
- Anticoagulant medications: Do NOT combine with warfarin (Coumadin), heparin, aspirin, clopidogrel, or other blood thinners without physician supervision — risk of excessive bleeding
- Surgery: Discontinue at least 2 weeks before any surgical procedure
- Bleeding disorders: Contraindicated in individuals with hemophilia or active bleeding conditions
- Pregnancy: Insufficient safety data — avoid during pregnancy
- Soy allergy: Most nattokinase supplements are soy-derived — check with manufacturer if you have soy sensitivity
Nattokinase vs. Pharmaceutical Thrombolytics
While nattokinase cannot replace emergency thrombolytic therapy (e.g., tPA for acute stroke), it occupies a valuable niche as a preventive and maintenance fibrinolytic agent. Its oral bioavailability, favorable safety profile, and multi-pathway mechanism make it uniquely suited for daily cardiovascular support — something pharmaceutical thrombolytics are far too aggressive for in routine use.
Bottom Line
Nattokinase is one of the most evidence-backed natural compounds for cardiovascular and circulatory health. Its ability to support healthy fibrinolysis, reduce blood pressure, address arterial plaque, and maintain healthy blood viscosity makes it a cornerstone supplement for anyone focused on heart health, longevity, or post-infectious circulatory support.
Used appropriately and with awareness of its blood-thinning properties, nattokinase is a powerful addition to an integrative cardiovascular protocol.
⚠ FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed physician before use, particularly if you are taking blood-thinning medications.
0 comments